0001209191-21-008138.txt : 20210205 0001209191-21-008138.hdr.sgml : 20210205 20210205165412 ACCESSION NUMBER: 0001209191-21-008138 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210204 FILED AS OF DATE: 20210205 DATE AS OF CHANGE: 20210205 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LEONHARDT HARRY J CENTRAL INDEX KEY: 0001286102 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39376 FILM NUMBER: 21596806 MAIL ADDRESS: STREET 1: C/O HALOZYME THERAPEUTICS, INC. STREET 2: 11388 SORRENTO VALLEY BLVD. CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Poseida Therapeutics, Inc. CENTRAL INDEX KEY: 0001661460 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 472846548 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9390 TOWNE CENTRE DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-779-3100 MAIL ADDRESS: STREET 1: 9390 TOWNE CENTRE DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-02-04 0 0001661460 Poseida Therapeutics, Inc. PSTX 0001286102 LEONHARDT HARRY J C/O POSEIDA THERAPEUTICS, INC. 9390 TOWNE CENTRE DRIVE, SUITE 200 SAN DIEGO CA 92121 0 1 0 0 GC & Chief Compliance Officer Employee Stock Option (Right to Buy) 9.15 2021-02-04 4 A 0 137000 0.00 A 2031-02-03 Common Stock 137000 137000 D 12.5% of the shares subject to the stock option will vest and become exercisable on the six-month anniversary of the grant date listed in column 3 above, and the remaining shares will vest in 42 equal monthly installments thereafter. /s/ Johanna Mylet, Attorney-in-Fact 2021-02-05